Pricing Log in Create free account
Friday 6 November 2026 Export RXRX’s income statement to Excel — free account

Recursion Pharmaceuticals, Inc.

RXRX Healthcare Biotechnology

Recursion Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $74.7 million, up 26.9% from fiscal 2024.

Revenue
+258.5%
EPS
+39.1%
Free cash flow
+33.8%
Total debt
−99.2%

Quarter to September 2026, against a year earlier

3.59 0.09 +2.57%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
−4.6×
Dividend yield
—
F-score
3/9
Altman Z
0.37
Beneish M
−1.72
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Recursion Pharmaceuticals, Inc. (RXRX) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Recursion Pharmaceuticals, Inc. (RXRX) trades at a P/B ratio of 2.1×. Over the past ten years it has ranged from 0.0× (June 2021) to 8.9× (July 2021); the current reading is higher than 27% of that period. That is in line with the Biotechnology industry median of 2.0× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.6× (9.66%)
FY2024 1.8× (59.54%)
FY2023 4.4× 62.27%
FY2022 2.7× (51.26%)
FY2022 5.6× 5.25%
FY2021 5.3× —
FY2021 0.0× —
FY2020 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period P/B ratio Change
Sep 2026 2.5× 15.92%
Jun 2026 2.1× 34.68%
Mar 2026 1.6× (2.01%)
Dec 2025 1.6× (22.33%)
23 more quarters

Against its own ten years

Low 0.0× High 8.9×
Ten-year median 2.9×
Current reading's percentile 24

P/B ratio against peers

Company P/B ratio
BHVN Biohaven Ltd. compare n/m
RXRX Recursion Pharmaceuticals, Inc. 2.1×
CLDX Celldex Therapeutics, Inc. compare 3.1×
NAMS NewAmsterdam Pharma Company N.V. compare 3.7×
MBX MBX Biosciences, Inc. compare 5.7×
PHVS Pharvaris N.V. compare 6.4×
ADMA ADMA Biologics Inc compare 6.7×
VCEL Vericel Corporation compare 6.8×
PVLA Palvella Therapeutics, Inc. compare 10.4×
Biotechnology industry median 2.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on RXRX